Aurelie Vanderlinden

Identification and Validation of ERK5 as a DNA Damage Modulating Drug Target in Glioblastoma

Natasha Carmell, Ola Rominiyi, Katie Myers et al. · Cancers · 2021 · 16 citations · Full text

DNA damage response inhibitors enhance tumour treating fields (TTFields) potency in glioma stem-like cells

Aurelie Vanderlinden, Callum Jones, Katie Myers et al. · British Journal of Cancer · 2023 · 15 citations · Full text

Inhibition of ATR opposes glioblastoma invasion through disruption of cytoskeletal networks and integrin internalization via macropinocytosis

Sarah Derby, Louise Dutton, Karen Strathdee et al. · Neuro-Oncology · 2023 · 15 citations · Full text